BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang X, Guo M, Fan J, Lv Z, Huang Q, Han J, Wu F, Hu G, Xu J, Jin Y. Prognostic significance of serum LDH in small cell lung cancer: A systematic review with meta-analysis. Cancer Biomark 2016;16:415-23. [PMID: 27062698 DOI: 10.3233/CBM-160580] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Fan S, Guan Y, Zhao G, An G. Association between plasma fibrinogen and survival in patients with small-cell lung carcinoma. Thorac Cancer 2018;9:146-51. [PMID: 29131503 DOI: 10.1111/1759-7714.12556] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
2 Choi EK, Park M, Im JJ, Chung YA, Oh JK. Prognostic value of 18F-FDG PET/CT metabolic parameters in small cell lung cancer. J Int Med Res 2020;48:300060519892419. [PMID: 31880209 DOI: 10.1177/0300060519892419] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Fu Y, Lan T, Cai H, Lu A, Yu W. Meta-analysis of serum lactate dehydrogenase and prognosis for osteosarcoma. Medicine (Baltimore) 2018;97:e0741. [PMID: 29742740 DOI: 10.1097/MD.0000000000010741] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 4.8] [Reference Citation Analysis]
4 Freis P, Graillot E, Rousset P, Hervieu V, Chardon L, Lombard-Bohas C, Walter T. Prognostic factors in neuroendocrine carcinoma: biological markers are more useful than histomorphological markers. Sci Rep. 2017;7:40609. [PMID: 28074897 DOI: 10.1038/srep40609] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
5 Liu X, Zhang W, Yin W, Xiao Y, Zhou C, Hu Y, Geng S. The prognostic value of the serum neuron specific enolase and lactate dehydrogenase in small cell lung cancer patients receiving first-line platinum-based chemotherapy. Medicine (Baltimore) 2017;96:e8258. [PMID: 29145241 DOI: 10.1097/MD.0000000000008258] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
6 de Jong C, Deneer VHM, Kelder JC, Ruven H, Egberts TCG, Herder GJM. Association between serum biomarkers CEA and LDH and response in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy. Thorac Cancer 2020;11:1790-800. [PMID: 32383328 DOI: 10.1111/1759-7714.13449] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
7 Liu Y, Li X, Yin Z, Lu P, Ma Y, Kai J, Luo B, Wei S, Liang X. Prognostic Prediction Models Based on Clinicopathological Indices in Patients With Resectable Lung Cancer. Front Oncol 2020;10:571169. [PMID: 33194667 DOI: 10.3389/fonc.2020.571169] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Grigorian-Shamagian L, Fereydooni S, Liu W, Echavez A, Marbán E. Harnessing the heart's resistance to malignant tumors: cardiac-derived extracellular vesicles decrease fibrosarcoma growth and leukemia-related mortality in rodents. Oncotarget 2017;8:99624-36. [PMID: 29245929 DOI: 10.18632/oncotarget.20454] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
9 Sonehara K, Tateishi K, Komatsu M, Yamamoto H, Hanaoka M. Lung immune prognostic index as a prognostic factor in patients with small cell lung cancer. Thorac Cancer 2020;11:1578-86. [PMID: 32286017 DOI: 10.1111/1759-7714.13432] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
10 Galvano A, Peri M, Guarini AA, Castiglia M, Grassadonia A, De Tursi M, Irtelli L, Rizzo S, Bertani A, Gristina V, Barraco N, Russo A, Natoli C, Bazan V. Analysis of systemic inflammatory biomarkers in neuroendocrine carcinomas of the lung: prognostic and predictive significance of NLR, LDH, ALI, and LIPI score. Ther Adv Med Oncol 2020;12:1758835920942378. [PMID: 32849916 DOI: 10.1177/1758835920942378] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
11 Li L, Pi C, Yan X, Lu J, Yang X, Wang C, Li X, Zhang S, Zhang Z, Sun Y, Hu Y. Prognostic Value of the Pretreatment Lung Immune Prognostic Index in Advanced Small Cell Lung Cancer Patients Treated With First-Line PD-1/PD-L1 Inhibitors Plus Chemotherapy. Front Oncol 2021;11:697865. [PMID: 34692478 DOI: 10.3389/fonc.2021.697865] [Reference Citation Analysis]
12 Li X, Chen C, Wang Z, Liu J, Sun W, Shen K, Lv Y, Zhu S, Zhan P, Lv T, Song Y. Elevated exosome-derived miRNAs predict osimertinib resistance in non-small cell lung cancer. Cancer Cell Int 2021;21:428. [PMID: 34391435 DOI: 10.1186/s12935-021-02075-8] [Reference Citation Analysis]
13 Jelinek D, Flores A, Uebelhoer M, Pasque V, Plath K, Iruela-Arispe ML, Christofk HR, Lowry WE, Coller HA. Mapping Metabolism: Monitoring Lactate Dehydrogenase Activity Directly in Tissue. J Vis Exp 2018. [PMID: 29985359 DOI: 10.3791/57760] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
14 Zhao Y, Wang R, Wang Y, Chen Q, Chen L, Hou W, Liu L, Gao W, Cheng B. Application of endoscopic ultrasound-guided-fine needle aspiration combined with cyst fluid analysis for the diagnosis of mediastinal cystic lesions. Thorac Cancer 2019;10:156-62. [PMID: 30480367 DOI: 10.1111/1759-7714.12924] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Wu J, Zan X, Gao L, Zhao J, Fan J, Shi H, Wan Y, Yu E, Li S, Xie X. A Machine Learning Method for Identifying Lung Cancer Based on Routine Blood Indices: Qualitative Feasibility Study. JMIR Med Inform 2019;7:e13476. [PMID: 31418423 DOI: 10.2196/13476] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
16 Pairawan S, Hess KR, Janku F, Sanchez NS, Mills Shaw KR, Eng C, Damodaran S, Javle M, Kaseb AO, Hong DS, Subbiah V, Fu S, Fogelman DR, Raymond VM, Lanman RB, Meric-Bernstam F. Cell-free Circulating Tumor DNA Variant Allele Frequency Associates with Survival in Metastatic Cancer. Clin Cancer Res 2020;26:1924-31. [PMID: 31852833 DOI: 10.1158/1078-0432.CCR-19-0306] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 5.7] [Reference Citation Analysis]
17 Zhou L, Xie Z, Shao Z, Chen W, Xie H, Cui X, Qin G, Zhao N. Modeling the relationship between baseline lactate dehydrogenase and prognosis in patients with extensive-disease small cell lung cancer: a retrospective cohort study. J Thorac Dis 2018;10:1043-9. [PMID: 29607179 DOI: 10.21037/jtd.2018.02.16] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
18 Lee S, Shim HS, Ahn BC, Lim SM, Kim HR, Cho BC, Hong MH. Efficacy and safety of atezolizumab, in combination with etoposide and carboplatin regimen, in the first-line treatment of extensive-stage small-cell lung cancer: a single-center experience. Cancer Immunol Immunother 2021. [PMID: 34568975 DOI: 10.1007/s00262-021-03052-w] [Reference Citation Analysis]
19 Li D, Yu H, Li W. Albumin-to-alkaline phosphatase ratio at diagnosis predicts survival in patients with metastatic non-small-cell lung cancer. Onco Targets Ther 2019;12:5241-9. [PMID: 31303770 DOI: 10.2147/OTT.S203321] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
20 Tae BS, Kim JK, Kang M, Jeong CW, Kwak C, Kim HH, Ku JH. Prognostic value of impaired estimated glomerular filtration rate in intravesical BCG-treated non-muscle-invasive bladder cancer patients. Sci Rep 2017;7:1380. [PMID: 28469275 DOI: 10.1038/s41598-017-01532-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
21 Gu W, Hu M, Wang W, Shi C, Mei J. Development and Validation of a Novel Nomogram for Predicting Tumor-Distant-Metastasis in Patients with Early T1-2 Stage Lung Adenocarcinoma. Ther Clin Risk Manag 2020;16:1213-25. [PMID: 33328735 DOI: 10.2147/TCRM.S272748] [Reference Citation Analysis]
22 Huang W, Liu P, Zong M, Chen QQ, Zhou H, Kong H, Xie WP. Combining Lactate Dehydrogenase and Fibrinogen: Potential Factors to Predict Therapeutic Efficacy and Prognosis of Patients with Small-Cell Lung Cancer. Cancer Manag Res 2021;13:4299-307. [PMID: 34103985 DOI: 10.2147/CMAR.S300153] [Reference Citation Analysis]